Thrombotic thrombocytopenic purpura screening: Difference between revisions
No edit summary |
|||
Line 15: | Line 15: | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for | There is no insufficient evidence to recommend routine screening for TTP. | ||
First test to be performe for TTP is screening for ADAMTS13 activity. | |||
*ADAMTS13 activity < 10%, TTP diagnosis is confirmed. | |||
==References== | ==References== |
Revision as of 20:02, 13 September 2018
Xyz Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thrombotic thrombocytopenic purpura screening On the Web |
American Roentgen Ray Society Images of Thrombotic thrombocytopenic purpura screening |
Risk calculators and risk factors for Thrombotic thrombocytopenic purpura screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is no insufficient evidence to recommend routine screening for TTP.
First test to be performe for TTP is screening for ADAMTS13 activity.
- ADAMTS13 activity < 10%, TTP diagnosis is confirmed.